A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States

GSK Investigational Site, New York

GSK Investigational Site, The Bronx

GSK Investigational Site, Great Neck

GSK Investigational Site, Manhasset

GSK Investigational Site, Brooklyn

GSK Investigational Site, Smithtown

GSK Investigational Site, Rochester

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Bethlehem

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Baltimore

GSK Investigational Site, Cumberland

GSK Investigational Site, Hagerstown

GSK Investigational Site, Winston-Salem

GSK Investigational Site, Chapel Hill

GSK Investigational Site, Greenville

GSK Investigational Site, Charleston

GSK Investigational Site, Charleston

GSK Investigational Site, Greenville

GSK Investigational Site, Atlanta

GSK Investigational Site, Orlando

GSK Investigational Site, Aventura

GSK Investigational Site, Tampa

GSK Investigational Site, Birmingham

GSK Investigational Site, Louisville

GSK Investigational Site, Columbus

GSK Investigational Site, Dayton

GSK Investigational Site, Munster

GSK Investigational Site, Lansing

GSK Investigational Site, Onalaska

GSK Investigational Site, Chicago

GSK Investigational Site, Chicago

GSK Investigational Site, Kansas City

GSK Investigational Site, Baton Rouge

GSK Investigational Site, Oklahoma City

GSK Investigational Site, Tulsa

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Sugar Land

GSK Investigational Site, San Antonio

GSK Investigational Site, Austin

GSK Investigational Site, Phoenix

GSK Investigational Site, Tucson

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Long Beach

GSK Investigational Site, Upland

GSK Investigational Site, Seattle

GSK Investigational Site, Ann Arbor

GSK Investigational Site, Arlington